ML385   Click here for help

GtoPdb Ligand ID: 10154

Synonyms: compound 2 [PMID: 27552339] | ML-385
Compound class: Synthetic organic
Comment: ML385 is a small molecule that binds to the Neh1 domain of the NRF2 transcription factor [6]. Activating mutations in NRF2 (and loss-of-function (LOF) mutations in KEAP1, a protein that binds NRF2 and targets it for proteosomal degradation) have been reported to facilitate cytoprotective functions which are associated with mechanisms of chemotherapy resistance and tumour expansion in various solid tumour types [2-5,8-9]. Evidence from preclinical and clinical studies has validated Inhibition of NRF2 as a novel mechanistic therapeutic approach for treatment-resistant tumours [1,7]. ML385 inhibits NRF2 activity in non-small cell lung cancer (NSCLC) cells with LOF KEAP1 mutations in vitro and inhibits tumour growth in xenograft models using KEAP1 mutant NSCLC cells (in combination with carboplatin) [6].
2D Structure
Click here for help
Click here for structure editor
Physico-chemical Properties
Click here for help
Hydrogen bond acceptors 5
Hydrogen bond donors 1
Rotatable bonds 7
Topological polar surface area 109
Molecular weight 511.16
XLogP 4.38
No. Lipinski's rules broken 0
SMILES / InChI / InChIKey
Click here for help
Canonical SMILES O=C(Nc1sc(c(n1)c1ccc2c(c1)CCN2C(=O)c1ccccc1C)C)Cc1ccc2c(c1)OCO2
Isomeric SMILES O=C(Nc1sc(c(n1)c1ccc2c(c1)CCN2C(=O)c1ccccc1C)C)Cc1ccc2c(c1)OCO2
InChI InChI=1S/C29H25N3O4S/c1-17-5-3-4-6-22(17)28(34)32-12-11-20-15-21(8-9-23(20)32)27-18(2)37-29(31-27)30-26(33)14-19-7-10-24-25(13-19)36-16-35-24/h3-10,13,15H,11-12,14,16H2,1-2H3,(H,30,31,33)
InChI Key LINHYWKZVCNAMQ-UHFFFAOYSA-N
Bioactivity Comments
ML385 inhibits NRF2-MAFG protein complex binding to ARE-DNA with an IC50 of 1900 nM [6]. ML385 directly binds NRF2's Neh1 domain.
Selectivity at other protein targets
Key to terms and symbols Click column headers to sort
Target Sp. Type Action Value Parameter Concentration range (M) Reference
nuclear factor, erythroid 2 like 2 Hs Inhibitor Binding - - - 6
[6]